Should we consider aldosterone as the primary screening target for preventing cardiovascular events?

Gary S. Francis, W. H.Wilson Tang

Research output: Contribution to journalEditorialpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1249-1250
Number of pages2
JournalJournal of the American College of Cardiology
Issue number8
StatePublished - Apr 19 2005

Bibliographical note

Funding Information:
Dr. Francis is a consultant for Novartis Pharmaceuticals and has received a research grant from Pfizer Pharmaceuticals to study eplerenone.

Cite this